A Study to Estimate the Occurrence of Rotavirus Gastroenteritis in Children < 5 Years of Age, in Bulgaria and Latvia
NCT01733849 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1266
Last updated 2017-01-18
Summary
This study aims to estimate the real situation of rotavirus gastroenteritis (RV GE) in the primary care settings of both Bulgaria and Latvia in children less than 5 years of age.
Conditions
- Infections, Rotavirus
Interventions
- OTHER
-
Stool sample
Samples will be tested to determine the presence or absence of rotavirus.
- OTHER
-
Data collection
Log books
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Eligibility
- Max Age
- 5 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-12-31
- Primary Completion
- 2014-06-30
- Completion
- 2014-06-30
Countries
- Bulgaria
- Latvia
Study Locations
More Related Trials
-
Hospital-based Surveillance to Collect Prospective Data to Estimate the Disease Burden of Severe RV GE in Sweden
NCT00489567 ·Status: COMPLETED
-
Observational Study on Rotavirus Gastroenteritis Epidemiology, Impact of Lyophilised vs. Liquid Formulation of Rotarix™
NCT01435967 ·Status: COMPLETED
-
Rotavirus Burden and Genotypes in a Sentinel Hospital Surveillance System in Lebanon
NCT01321216 ·Status: COMPLETED
-
Study to Assess the Impact of Vaccination on Hospitalizations and Outpatient Visits Due to Rotavirus Gastroenteritis
NCT01733862 ·Status: COMPLETED
-
Effectiveness of Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants in Panama
NCT00653198 ·Status: COMPLETED
-
Vaccine Effectiveness of RV1 in a Naïve Population
NCT01467037 ·Status: COMPLETED
-
Effectiveness of Monovalent Rotavirus Vaccine (RV1)
NCT01871038 ·Status: COMPLETED
-
Impact of Rotavirus Vaccination on Hospital Pressures at a Large Paediatric Hospital in the UK: an Ecological Study
NCT03271593 ·Status: COMPLETED
-
Study to Analyze the Clinical and Cost Impact of Complete and Incomplete Rotavirus (RV) Vaccination
NCT01682005 ·Status: COMPLETED
-
Surveillance of Rotavirus Gastroenteritis in Children <5 Years
NCT01363726 ·Status: UNKNOWN
-
Impact of Systematic Infants Vaccination Against Rotavirus on Gastroenteritis Hospitalization: a Prospective Study in Brest District, France.
NCT00740935 ·Status: COMPLETED ·Phase: PHASE4
-
The Efficacy of Three Doses of Live Attenuated, Oral Rotavirus Vaccine 116E
NCT05958771 ·Status: UNKNOWN ·Phase: PHASE3
-
Evaluation of the Human Rotavirus Vaccine at Varying Schedules and Doses in Rural Ghana
NCT01575197 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Effectiveness of Rotarix™ Against Severe Gastroenteritis Among Hospitalized Children in Brazil
NCT01177657 ·Status: COMPLETED
-
Reactogenicity, Safety and Immunological Efficacy of the Live, Pentavalent Rotavirus Vaccine in Childhood Immunization
NCT05032391 ·Status: COMPLETED ·Phase: PHASE3
-
Rotavirus Gastroenteritis and Vaccine Usage in Rhode Island
NCT01026779 ·Status: COMPLETED
-
Effectiveness of Human Rotavirus Vaccine, Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants
NCT00655187 ·Status: COMPLETED
-
Introduction of an Oral Live Human Rotavirus (Rotarix) Vaccine in Matlab
NCT00737503 ·Status: COMPLETED ·Phase: PHASE4
-
Glycan Attachment Specificity, Toward ROtavirus Vaccine IMprovement GASTROVIMc (Clinical Investigation)
NCT02902445 ·Status: COMPLETED
-
Canadian Rotavirus Surveillance Through the Immunization Monitoring Program Active (IMPACT)
NCT01633190 ·Status: UNKNOWN
-
Impact of Rotavirus Vaccination on Hospitalisations for Rotavirus Gastroenteritis in Children Aged <5 Years in Australia
NCT01236066 ·Status: COMPLETED
-
Epidemiology of Rotavirus Infection in North India Community
NCT01508533 ·Status: COMPLETED
-
Impact on Quality of Hospital Care During Pre- and Post- Rotavirus (RV) Vaccination Introduction in Belgium
NCT01592838 ·Status: COMPLETED
-
The Efficacy of Oral Rotavirus Vaccine 116E (ROTAVAC 5D) in Chilean Infants
NCT06200844 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Phase III Clinical Trial to Evaluate the Protective Efficacy of Three Doses of Oral Rotavirus Vaccine (ORV) 116E
NCT01305109 ·Status: UNKNOWN ·Phase: PHASE3